CytomX Therapeutics (CTMX) Non Operating Income (2016 - 2017)
CytomX Therapeutics (CTMX) posted Non Operating Income of $806000.0 for Q3 2017, up 125.77% on a QoQ basis from $357000.0 in Q2 2017, and up 283.81% year-over-year from $210000.0 in Q3 2016.
CytomX Therapeutics (CTMX) Non Operating Income (2016 - 2017) Analysis & Trends
CytomX Therapeutics' Non Operating Income history runs 2 years deep, the most recent figure standing at $806000.0 for Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | CytomX Therapeutics | 574.36 Mn | 227.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 806,000.00 |
| Jun 30, 2017 | 357,000.00 |
| Sep 30, 2016 | 210,000.00 |
| Jun 30, 2016 | 195,000.00 |